Yang Feng
20Patents
4h-index
21Co-inventors
59Inventor score
Filing activity: Dec 30, 2003 → Apr 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8667381B1 | Block diagram change history | Physics | 14 | Active |
| US8584088B1 | Identification of patterns in modeling environments | Physics | 11 | Active |
| US8357783B2 | Human anti-mesothelin monoclonal antibodies | Chemistry; Metallurgy | 10 | Active |
| US7500220B1 | Shared code management | Physics | 10 | Active |
| US8105598B2 | Human monoclonal antibodies that specifically bind IGF-II | Physics | 4 | Active |
| US8726232B1 | Identification of patterns in modeling environments | Physics | 3 | Active |
| US8871206B2 | Anti-human folate receptor beta antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
| US8225276B1 | Shared code management | Physics | 1 | Active |
| US10633441B2 | Mesothelin-targeted chimeric antigen receptors and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9044457B2 | Anti-DR4 agonist antibodies | Chemistry; Metallurgy | 0 | Active |
| US9963505B2 | Anti-human folate receptor beta antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12229577B2 | Virtual machine file management using file-level snapshots | Physics | 0 | Active |
| US7824681B2 | Human monoclonal antibodies that specifically bind IGF-II | Physics | 0 | Active |
| US10548987B2 | Antibody-drug conjugates for targeting CD56-positive tumors | Chemistry; Metallurgy | 0 | Active |
| US9127056B2 | Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II) | Chemistry; Metallurgy | 0 | Active |
| US10538588B2 | Mesothelin-targeted chimeric antigen receptors and methods of making them | Chemistry; Metallurgy | 0 | Active |
| US10730941B2 | Antigen-binding proteins targeting CD56 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11702472B2 | Method of reducing mesothelin-expressing tumor burden by administration of T cells comprising mesothelin-targeted chimeric antigen receptors | Chemistry; Metallurgy | 0 | Active |
| US12018077B2 | Methods of treatments using antigen-binding proteins targeting CD56 | Chemistry; Metallurgy | 0 | Active |
| US9914773B2 | Anti-human folate receptor beta antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.